Delivery Order SPE2DB22D2009-SPE2DB25FM0TY
- Not listed
- The Defense Logistics Agency awarded a $2,280.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $8,642.97 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price delivery order represents a non-set-aside competitive award issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor and healthcare solutions provider. The contract will be performed at the awardee's corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award for continuous glucose monitoring devices to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 7, 2025, with a ceiling value of $1,031.20. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle, is set to be completed by August 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. No set-aside designation was...
- The Defense Logistics Agency awarded a delivery order valued at $1,546.80 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,295.99 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 12, 2025, with a completion date of August 13, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Dexcom G7 sensors are continuous glucose monitoring devices used for diabetes management, supporting the...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed-price delivery order, issued on August 11, 2025, with a completion date of August 12, 2025, represents a non-competitive set-aside award. The sensors will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the agency's medical supply chain operations for federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management, aligning with the company's extensive portfolio of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,474.88 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This firm fixed price, non-competitive delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a federal medical supply provider,...
- The Defense Logistics Agency awarded a $14,958.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of July 21, 2025. This non-set-aside contract was competitively awarded on July 18, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management within military and federal healthcare...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0TYDelivery Order
The Defense Logistics Agency awarded a $2,062.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive set-aside delivery order under a larger indefinite delivery contract (IDC) vehicle. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device supply. This delivery order is a child contract under AmerisourceBergen's substantial $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and supports global pharmaceutical and medical supply needs for military healthcare programs. The Dexcom G7 sensors represent specialized medical commodities within the broader scope of the pharmaceutical prime vendor program, enabling support to the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's established position as a critical vendor for DLA medical procurement demonstrates its capability to fulfill specialized medical device requirements through the existing contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/8/25 |